Professor Dr. Wolfgang Plischke has been a member of the Board of Management of Bayer AG since March 1, 2006. He is responsible for Technology, Innovation and Sustainability, and for the Asia/Pacific region.
Wolfgang Plischke was born in Stuttgart, Germany on September 15, 1951. He studied biology at Hohenheim University before starting his career in 1980 with Bayer’s subsidiary Miles Diagnostics. In 1995 he became President of Bayer Yakuhin Ltd., Japan, with responsibility for Pharmaceuticals and Consumer Care. In 2000 Prof. Dr. Plischke took over as head of the Pharmaceuticals Business Group in North America.
In January 2002 he was appointed head of the Pharmaceuticals Business Group at Bayer AG with responsibility for the global business with prescription drugs.
Prof. Dr. Plischke also holds a number of offices outside of Bayer AG. He is a member of the board of the Walter Siegenthaler Society, the German Asia-Pacific Business Association and the Robert Koch Foundation. In addition, he is a member of the boards of trustees of the Paul Ehrlich Foundation and the German Chemical Industry Fund. Prof. Dr. Plischke is also Vice President of the European Chemical Industry Council (CEFIC) as well as chairman of CEFIC’s Programme Council “Research and Innovation” and of the committee “Healthcare” of the Federation of German Industries (BDI).
In July 2011 Wolfgang Plischke was appointed honorary professor for Business Chemistry at the Ludwig Maximilian University of Munich.
Professor Dr. Wolfgang Plischke is married and has two sons.